was greater than 10mm in 8 patients. Histologically 46.2% were T1 tumours, 34.6% were T2, 7.7% were T3 and 11.5% were T4. The liver capsule was intact in 20 patients, only 2 patients had direct involvement of adjacent organs and one demonstrated vascular invasion at histopathological analysis. No associated surgical complications were documented in this group. Average disease free survival was 24.5 months, and the average overall survival was 31.6 months. Conclusions: HCC is an increasing diagnosis, with many treatment options. Given the background of cirrhosis, a small proportion of patients are deemed suitable for surgical resection. However when appropriate, it remains a safe and effective treatment option, which may positively impact on survival. Further larger studies are required to validate this.